Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Retrieved 2016-03-02
For biosimilar developers, the equivalent analysis focuses on the 351(k) landscape: reference product exclusivity expiration dates (which establish the earliest possible FDA approval date), the biosimilar patent dance posture (whether to engage or opt out), and the competitive field of other biosimilar developers targeting the same reference product
The timing of a pregnancy test can have a huge impact on its accuracy
One study found that lactating women taking 2-60 mg of niacin daily had milk niacin concentrations of 1.17-2.75 g/mL
Access this chapter Subscribe and save Buy Now Tax calculation will be finalised at checkout Purchases are for personal use only References Manning MC, Patel K, Borchardt RT (1989) Stability of protein pharmaceuticals
US$ 20.66
US$ 23.45
US$ 22.84
US$ 20.00
US$ 25.37
US$ 20.11
US$ 24.53
